Live Breaking News & Updates on Nasdaq Gbs

Stay updated with breaking news from Nasdaq gbs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

GBS Inc. Reports Fourth Quarter and Full Year ended June

- Entered into exclusive agreement with Intelligent Fingerprinting Ltd. (IFP) for screening technology focused on drugs of abuse towards a prospective. ....

United States , New South Wales , George Margelis , Tom Parmakellis , Lawrence Fisher , Steven Boyages , Prospective Acquisition Of Intelligent Fingerprinting Ltd , Diabetes Research Institute Of Sutter Health , Compensation Committee , Strategic Partnerships Pipeline Development , University Of Sydney , Audit Committee , Development Commercialization , Peninsula Medical Center , Clinical Professor Of The Sydney Medical School , University Of Newcastle , Intelligent Fingerprinting Ltd , Intelligent Fingerprinting , Glucose Biosensor , Diabetes Research Institute , Sutter Health , Mills Peninsula Medical Center , San Mateo , Interim Chief Executive Officer , Full Year Highlights , Recent Operational ,

GBS Inc. to Initiate Manufacturing on the University of

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for. ....

Alex Arzeno , Paul Dastoor , Tim Mccarthy , Steven Boyages , Ir Communications , Centre For Organic Electronics , Lifesci Advisors , Company Contact , University Of Newcastle , Gbs Inc , Interim Chief Executive , Professor Paul Dastoor , Organic Electronics , Biosensor Platform , Vice President , Sci Advisors , Nasdaq Gbs ,

GBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on

NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for. ....

Alex Arzeno , Tim Mccarthy , Exchange Commission , Ir Communications , Lifesci Advisors , Company Contact , Securities Exchange , Gbs Inc , Call Details , Eastern Time , Annual Meeting , Looking Statements , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Biosensor Platform , Vice President , Sci Advisors , Nasdaq Gbs ,

GBS Inc. Reports Third Quarter 2022 Financial Results and

- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University. ....

United States , Steven Boyages , Biosensor Algorithm Development , Department Of Pathology , University Of Newcastle , Quest Diagnostics , Clinical Development , Cash Equivalents , Marketable Securities , Institutional Review Board , Chief Executive Officer , Johns Hopkins Hospital , Status Updates , Specimen Collection Methodology , Support Subsequent Correlation , Oral Fluids , Venous Blood , Algorithm Development , North American , Webcast Registration , Nasdaq Gbs , Gbs Inc ,

GBS Inc. to Present Third Quarter 2022 Financial Results

Company to Host Conference Call & Webcast at 4:30 p.m. ET. ....

Alex Arzeno , Tim Mccarthy , Ir Communications , Lifesci Advisors , Company Contact , Gbs Inc , Third Quarter , Call Details , Biosensor Platform , Vice President , Sci Advisors , Nasdaq Gbs ,